Vivtex 2023 Timeline
Share
October 16 & 17th
Vivtex CSO, Thomas von Erlach, participates in an exciting panel discussion at the 13th Annual PODD Conference in Boston, MA.
September 6 & 7th
Vivtex CEO Maureen Deehan presents at the New York Venture Summit. An opportunity to showcase Vivtex and detail our journey so far.
February 21st
Vivtex Announces Promotion of Maureen Deehan To Chief Executive Officer
“We are delighted that Maureen, who has an outstanding background in both science and business, has accepted our offer to be CEO,” said Robert Langer, a co-founder and Board member of Vivtex.
Dr. Deehan joined Vivtex in December 2022 as the Chief Business & Operating Officer.
She is a biotechnology and pharmaceutical professional with 22 years of drug development and commercialization experience.
Her last nine years have been spent in global corporate development roles at Novimmune SA and Nordic Nanovector ASA, where she had a very successful track record in business development and deal-making, for product and technology platform transactions, with a range of companies, including Genentech and Shire.
